id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-P-0512-0003,FDA,FDA-2011-P-0512,Academy of Managed Care Pharmacy - Letter,Other,Letter(s),2011-08-26T04:00:00Z,2011,8,2011-08-26T04:00:00Z,,2011-08-26T15:06:01Z,,0,0,0900006480ed284a
FDA-2011-P-0512-0001,FDA,FDA-2011-P-0512,"Allergan, Inc., Eli Lilly, Johnson & Johnson, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfizer, Inc. and sanofi-aventis US LLC (Ropes & Gray) - Citizen Petition",Other,Citizen Petition,2011-07-12T04:00:00Z,2011,7,2011-07-12T04:00:00Z,,2014-12-22T23:23:23Z,,0,0,0900006480eba5de
FDA-2011-P-0512-0002,FDA,FDA-2011-P-0512,"Acknowledgement Letter to Allergan, Inc., et al., (Ropes & Gray)",Other,Acknowledgement Letter/Receipt,2011-07-12T04:00:00Z,2011,7,2011-07-12T04:00:00Z,,2011-07-12T18:59:37Z,,0,0,0900006480eba5df